New obesity drug tirzepatide put to the test in paraguay hospital study
NCT ID NCT07492563
First seen Mar 25, 2026 · Last updated May 06, 2026 · Updated 7 times
Summary
This study will check how safe and effective the drug tirzepatide is for 300 adults with obesity or overweight plus related health problems like type 2 diabetes. Participants will take the medicine as part of their regular care and be followed for 12 months. The main goal is to track side effects, and researchers will also measure weight loss, blood sugar control, and patient satisfaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Endocrinology Unit, UNA, Py
Asunción, Paraguay
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.